ClinVar Miner

Submissions for variant NM_000371.3(TTR):c.360C>T (p.Ser120=) (rs150127220)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 8
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories RCV000589654 SCV000884815 benign not provided 2017-10-18 criteria provided, single submitter clinical testing
Ambry Genetics RCV000253403 SCV000317523 benign Cardiovascular phenotype 2014-12-18 criteria provided, single submitter clinical testing
Athena Diagnostics Inc RCV000036374 SCV000616217 benign not specified 2017-02-15 criteria provided, single submitter clinical testing
CHEO Genetics Diagnostic Laboratory,Children's Hospital of Eastern Ontario RCV000770560 SCV000902008 benign Cardiomyopathy 2017-07-10 criteria provided, single submitter clinical testing
Illumina Clinical Services Laboratory,Illumina RCV000206233 SCV000408395 uncertain significance Amyloidogenic transthyretin amyloidosis 2016-06-14 criteria provided, single submitter clinical testing
Integrated Genetics/Laboratory Corporation of America RCV000589654 SCV000696630 benign not provided 2016-06-22 criteria provided, single submitter clinical testing Variant summary: The TTR c.360C>T (p.Ser120Ser) variant causes a synonymous change involving a non-conserved nucleotide with 5/5 splice prediction tools predicting no significant impact on splicing and ESE finder predicts changes of binding motifs for RNA splicing enhancers, although these predictions have yet to be functionally assessed. The variant of interest was observed in the large, broad control population, ExAC, with an allele frequency of 339/121120 (1/357, 7 homozygotes), which significantly exceeds the estimated maximal expected allele frequency for a pathogenic TTR variant of 1/31948 (0.0000313), suggesting this variant is likely a benign polymorphism. In addition, multiple clinical diagnostic laboratories classified this variant as benign. Taken together, this variant is classified as benign.
Invitae RCV000206233 SCV000261520 benign Amyloidogenic transthyretin amyloidosis 2017-12-29 criteria provided, single submitter clinical testing
Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine RCV000036374 SCV000060027 benign not specified 2015-03-11 criteria provided, single submitter clinical testing p.Ser120Ser in exon 4 of TTR: This variant is not expected to have clinical sign ificance because it has been identified in 3.5% (300/8636) of East Asian chromos omes by the Exome Aggregation Consortium (ExAC,; dbSNP rs150127220).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.